Clinical trial
Treatment of Depression in Parkinson's Disease Trial
NCT00062738 · Rutgers, The State University of New Jersey, Other · Completed
Key facts
| NCT number | NCT00062738 |
|---|---|
| Title | Treatment of Depression in Parkinson's Disease Trial |
| Official title | Treatment of Depression in Patients With Parkinson's Disease |
| Lead sponsor | Rutgers, The State University of New Jersey, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson Disease, Depression |
| Intervention type | Drug, Other |
| Interventions | paroxetine, Nortriptyline, placebo |
| Enrollment | 52 |
| Start date | Jun 1, 2003 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jun 13, 2003 |
| Last update posted | Nov 24, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: